Abstract:Aim To search for a novel nonsteroidal antiinflammatory drug with high potency and low undesirable effects.Methods Coupling flobufen,a new chemical entity in phase Ⅲ clinical trials,with NO donors having different NO releasing mechanisms,in which NO synthase(NOS)substrate analogues,nitrates and furoxans are included.Evaluating antiinflammatory activities against the xylene-induced mice ear swelling and carrageenan-induced rat paw edema,observing side effects in the rat gastrointestinal(GI)tract and assessing NO releasing ability.Results Nineteen target compounds were synthesized,their structures were determined by MS,IR, 1H-NMR and elemental analysis.The preliminary pharmacological tests showed that 10 target compounds(Ⅰ_1,Ⅰ_ 3～5 ,Ⅰ_8,Ⅰ_ 12 ,Ⅱ_2,Ⅱ_3,Ⅱ_6,Ⅱ_7 )displayed relatively high antiinflammatory activities,among which 5(Ⅰ_1,Ⅰ_3,Ⅰ_4,Ⅱ_3,Ⅱ_6 )possessed activity comparable to flobufen( P 0.05).All the active compounds showed low GI side effects,among which GI lesions of Ⅰ_1,Ⅰ_3,Ⅰ_5 and Ⅱ_7 were significantly less than that of flobufen( P 0.05).Ⅰ_1 and Ⅰ_3 showed comparable antiinflammatory activites to flobufen,while their GI side effects were significantly lower than that of flobufen.Conclusion Compounds Ⅰ_1 and Ⅰ_3 ,which were on the whole superior to flobufen,are worthy to be intensively studied.

Study on NO-Donating Antihypertensive AgentsI. Synthesis and Antihypertensive Activity of C-3 Nitrate or Furoxan Substituted Benzopyrans

Study on NO-donating antihypertensive agents I. Synthesis and antihypertensive activity of C-3 nitrate or furoxan substituted benzopyrans

Synthesis and anti-hypertensive activity of C-4 substituted NO-donating benzopyran derivatives

Design, Synthesis and Pharmacological Evaluation of Novel NO-Releasing Benzimidazole Hybrids as Potential Antihypertensive Candidate.

Novel Nitric Oxide-Releasing Isochroman-4-one Derivatives: Synthesis and Evaluation of Antihypertensive Activity.

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Synthesis and Biological Evaluations of Novel Nitric Oxide-donating Derivatives of [1,2,4]triazol-5(4H)-one with N-phenylpyrrolyl-2-tetrazole Moiety as Anti-hypertension Candidates

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1h-[1,2,4]triazol-5(4h)-one Derivatives As Anti-Hypertension Drugs

Synthesis and Biological Activities of Oxaprozin Derivatives

Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities

Effect of NO donating-benzopyran compound II-7 on spontaneously hypertensive rats and NO releasing in vitro

Synthesis and Vascular Relaxing Activity of Arecoline Derivatives Coupled with Nitric Oxide Donors

Synthesis and Antitumor Activity of Nitric Oxide Releasing Derivatives of AT1 Antagonist

Design, Synthesis, and Biological Evaluation of 1,2,4-Triazole Bearing 5-Substituted Biphenyl-2-sulfonamide Derivatives As Potential Antihypertensive Candidates

Design, Synthesis and Biological Evaluation of 6-Substituted Aminocarbonyl Benzimidazole Derivatives As Nonpeptidic Angiotensin II AT1 Receptor Antagonists.

Design, Synthesis and Biological Evaluation of Hydrogen Sulfide-Releasing Isochroman-4-one Derivatives As New Antihypertensive Agent Candidates.

Design, Synthesis and Biological Evaluation of Isochroman-4-one Hybrids Bearing Piperazine Moiety As Antihypertensive Agent Candidates

Synthesis and Antiinflammatory Activities of NO Releasing-Flobufen Derivatives

Synthesis and Antihypertensive Activity Evaluation in Spontaneously Hypertensive Rats of Nitrendipine Analogues

Phenylsulfonylfuroxan NO-donor Phenols: Synthesis and Multifunctional Activities Evaluation.

Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates.